1. Home
  2. BPTH vs NVFY Comparison

BPTH vs NVFY Comparison

Compare BPTH & NVFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPTH
  • NVFY
  • Stock Information
  • Founded
  • BPTH 2007
  • NVFY 2003
  • Country
  • BPTH United States
  • NVFY United States
  • Employees
  • BPTH N/A
  • NVFY N/A
  • Industry
  • BPTH Biotechnology: Pharmaceutical Preparations
  • NVFY Home Furnishings
  • Sector
  • BPTH Health Care
  • NVFY Consumer Discretionary
  • Exchange
  • BPTH Nasdaq
  • NVFY Nasdaq
  • Market Cap
  • BPTH 4.8M
  • NVFY 4.0M
  • IPO Year
  • BPTH N/A
  • NVFY N/A
  • Fundamental
  • Price
  • BPTH $0.73
  • NVFY $0.62
  • Analyst Decision
  • BPTH Strong Buy
  • NVFY
  • Analyst Count
  • BPTH 2
  • NVFY 0
  • Target Price
  • BPTH $30.00
  • NVFY N/A
  • AVG Volume (30 Days)
  • BPTH 161.7K
  • NVFY 25.2K
  • Earning Date
  • BPTH 03-07-2025
  • NVFY 11-14-2024
  • Dividend Yield
  • BPTH N/A
  • NVFY N/A
  • EPS Growth
  • BPTH N/A
  • NVFY N/A
  • EPS
  • BPTH N/A
  • NVFY N/A
  • Revenue
  • BPTH N/A
  • NVFY $9,955,064.00
  • Revenue This Year
  • BPTH N/A
  • NVFY N/A
  • Revenue Next Year
  • BPTH N/A
  • NVFY N/A
  • P/E Ratio
  • BPTH N/A
  • NVFY N/A
  • Revenue Growth
  • BPTH N/A
  • NVFY N/A
  • 52 Week Low
  • BPTH $0.59
  • NVFY $0.39
  • 52 Week High
  • BPTH $10.00
  • NVFY $4.42
  • Technical
  • Relative Strength Index (RSI)
  • BPTH 37.30
  • NVFY 48.84
  • Support Level
  • BPTH $0.78
  • NVFY $0.49
  • Resistance Level
  • BPTH $0.84
  • NVFY $0.68
  • Average True Range (ATR)
  • BPTH 0.05
  • NVFY 0.07
  • MACD
  • BPTH -0.02
  • NVFY 0.00
  • Stochastic Oscillator
  • BPTH 4.05
  • NVFY 55.37

About BPTH Bio-Path Holdings Inc.

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.

About NVFY Nova Lifestyle Inc.

Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.

Share on Social Networks: